UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Epigenetic MMR defect identifies a risk group not accounted for through traditional risk stratification algorithms in endometrial cancer

Frontiers in oncology, 2023-04, Vol.13, p.1147657-1147657

2023

Volltextzugriff (PDF)

Learning to lead: The evolution of a pilot leadership curriculum for gynecologic oncology fellows at the Ohio State University

Gynecologic oncology reports, 2024-04, Vol.52, p.101327, Article 101327

2024

Volltextzugriff (PDF)

Recurrence rate in early-stage epithelial ovarian cancer: Is there a role for upfront maintenance with PARP inhibitors in stages I and II?

Gynecologic oncology reports, 2023-04, Vol.46, p.101173-101173, Article 101173

2023

Volltextzugriff (PDF)

Targeted Therapies in Low-Grade Serous Ovarian Cancers

Current treatment options in oncology, 2024-07, Vol.25 (7), p.854-868

2024

Volltextzugriff (PDF)

Assessment of the feasibility of same-day discharge following minimally invasive hysterectomy in the elderly population

Gynecologic oncology reports, 2023-08, Vol.48, p.101227-101227, Article 101227

2023

Volltextzugriff (PDF)

The right time for change: A report on the heterogeneity of IVB endometrial cancer and improved risk-stratification provided by new 2023 FIGO staging criteria

Gynecologic oncology, 2023-08, Vol.175, p.32-40

2023

Volltextzugriff (PDF)

“More than a song and dance”: Exploration of patient perspectives and educational quality of gynecologic cancer content on TikTok

Gynecologic oncology, 2023-08, Vol.175, p.81-87

2023

Volltextzugriff (PDF)

Pembrolizumab with or without bevacizumab for recurrent or metastatic cervical cancer: A cost-effectiveness analysis

Gynecologic oncology, 2022-06, Vol.165 (3), p.500-505

2022

Volltextzugriff (PDF)

Characterization of mismatch‐repair/microsatellite instability‐discordant endometrial cancers

Cancer, 2024-02, Vol.130 (3), p.385-399

2024

Volltextzugriff (PDF)

Cold ischemia time and formalin fixation time in endometrial cancer: Should breast cancer guidelines for preanalytical variables be applied to hysterectomy specimens?

Gynecologic oncology, 2024-12, Vol.191, p.194-200

2024

Volltextzugriff (PDF)

Authentic leadership in action: Experience gained from a gynecologic oncology fellowship leadership curriculum

Gynecologic oncology, 2024-03, Vol.182, p.176-178

2024

Volltextzugriff (PDF)

Lenvatinib plus pembrolizumab in advanced recurrent endometrial cancer: A cost-effectiveness analysis

Gynecologic oncology, 2021-09, Vol.162 (3), p.626-630

2021

Volltextzugriff (PDF)

Reply to “Mismatch repair and microsatellite instability—Recommendation for an optimal test strategy”

Cancer, 2024-05, Vol.130 (9), p.1713-1714

2024

Volltextzugriff (PDF)

Cost-effectiveness of chemotherapy and dostarlimab for advanced or recurrent endometrial cancer

Gynecologic oncology, 2024-04, Vol.183, p.78

2024

Volltextzugriff (PDF)

Retraction notice to “Cost-effectiveness of chemotherapy and dostarlimab for advanced or recurrent endometrial cancer” [Gynecologic Oncology 183 (2024) 78–84]

Gynecologic oncology, 2024-04, Vol.183, p.R1-R1

2024

Volltextzugriff (PDF)

RETRACTED: Cost-effectiveness of chemotherapy and dostarlimab for advanced or recurrent endometrial cancer

Gynecologic oncology, 2024-04, Vol.183, p.78-84

2024

Volltextzugriff (PDF)

The impact of antibiotic and proton pump inhibitor use at the time of adjuvant platinum-based chemotherapy on survival in patients with endometrial cancer

Gynecologic oncology, 2023-11, Vol.178, p.14-22

2023

Volltextzugriff (PDF)

Cervical carcinoma with histologic components of sarcomatoid carcinoma and multiple basaloid variants: A case report and review of the literature

Gynecologic oncology reports, 2021-08, Vol.37, p.100797, Article 100797

2021

Volltextzugriff (PDF)

Lateral thoracotomy for epicardial pacemaker placement in patients with congenital heart disease

Interactive cardiovascular and thoracic surgery, 2018-05, Vol.26 (5), p.845-851

2018

Volltextzugriff (PDF)

Large vulvar hematoma secondary to obturator artery pseudoaneurysm following uncomplicated vaginal delivery: A case report and review of the literature

Journal of Case Reports and Images in Obstetrics and Gynecology, 2021, Vol.7, p.1-5

2021

Volltextzugriff (PDF)

222: Does a week matter? Timing of repeat cesarean delivery for women with prior classical incision

American journal of obstetrics and gynecology, 2020-01, Vol.222 (1), p.S154-S155

2020

Volltextzugriff (PDF)

Retraction notice to "Cost-effectiveness of chemotherapy and dostarlimab for advanced or recurrent endometrial cancer" Gynecologic Oncology 183 (2024) 78-84

Gynecologic oncology, 2024-04, Vol.183, p.R1

2024

Volltextzugriff (PDF)

Cervical carcinoma with histologic components of sarcomatoid carcinoma and multiple basaloid variants: A case report and review of the literature

Gynecologic oncology reports, 2021, Vol.37, p.100797-100797

2021

Volltextzugriff (PDF)

Bridging the Gap from Bench to Bedside: A Call for In Vivo Preclinical Models to Advance Endometrial Cancer and Cervical Cancer Immuno-oncology Research

Clinical cancer research, 2024-07, Vol.30 (14), p.2905-2909

2024

Volltextzugriff (PDF)

1 – 25 von 26

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(24)
Mit Volltextzugriff
(24)

Publikationsform

Artikel
(25)
Berichte
(1)

Sprache

Englisch
(26)

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(20)
Science & Technology
(20)
Oncology
(15)
Obstetrics & Gynecology
(14)
Humans
(12)
Female
(11)
Endometrial Cancer
(5)
Endometrial Neoplasms - Pathology
(5)
Cost-Effectiveness
(3)
Neoplasm Staging
(3)
Retrospective Studies
(3)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(2)
Biomarker
(2)
Cohort Studies
(2)
Cost-Benefit Analysis
(2)
Curriculum
(2)
Dna Mismatch Repair - Genetics
(2)
Fellowship
(2)
Immunohistochemistry
(2)
Leadership
(2)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Epigenetic MMR defect identifies a risk group not accounted for through traditional risk stratification algorithms in endometrial cancer

Learning to lead: The evolution of a pilot leadership curriculum for gynecologic oncology fellows at the Ohio State University

Recurrence rate in early-stage epithelial ovarian cancer: Is there a role for upfront maintenance with PARP inhibitors in stages I and II?

Targeted Therapies in Low-Grade Serous Ovarian Cancers

Assessment of the feasibility of same-day discharge following minimally invasive hysterectomy in the elderly population

The right time for change: A report on the heterogeneity of IVB endometrial cancer and improved risk-stratification provided by new 2023 FIGO staging criteria

“More than a song and dance”: Exploration of patient perspectives and educational quality of gynecologic cancer content on TikTok

Pembrolizumab with or without bevacizumab for recurrent or metastatic cervical cancer: A cost-effectiveness analysis

Characterization of mismatch‐repair/microsatellite instability‐discordant endometrial cancers

Cold ischemia time and formalin fixation time in endometrial cancer: Should breast cancer guidelines for preanalytical variables be applied to hysterectomy specimens?

Authentic leadership in action: Experience gained from a gynecologic oncology fellowship leadership curriculum

Lenvatinib plus pembrolizumab in advanced recurrent endometrial cancer: A cost-effectiveness analysis

Reply to “Mismatch repair and microsatellite instability—Recommendation for an optimal test strategy”

Cost-effectiveness of chemotherapy and dostarlimab for advanced or recurrent endometrial cancer

Retraction notice to “Cost-effectiveness of chemotherapy and dostarlimab for advanced or recurrent endometrial cancer” [Gynecologic Oncology 183 (2024) 78–84]

RETRACTED: Cost-effectiveness of chemotherapy and dostarlimab for advanced or recurrent endometrial cancer

The impact of antibiotic and proton pump inhibitor use at the time of adjuvant platinum-based chemotherapy on survival in patients with endometrial cancer

Safety and feasibility of same-day discharge following minimally invasive hysterectomy in the morbidly obese patient population

Cervical carcinoma with histologic components of sarcomatoid carcinoma and multiple basaloid variants: A case report and review of the literature

Lateral thoracotomy for epicardial pacemaker placement in patients with congenital heart disease

Large vulvar hematoma secondary to obturator artery pseudoaneurysm following uncomplicated vaginal delivery: A case report and review of the literature

222: Does a week matter? Timing of repeat cesarean delivery for women with prior classical incision

Retraction notice to "Cost-effectiveness of chemotherapy and dostarlimab for advanced or recurrent endometrial cancer" Gynecologic Oncology 183 (2024) 78-84

Cervical carcinoma with histologic components of sarcomatoid carcinoma and multiple basaloid variants: A case report and review of the literature

Bridging the Gap from Bench to Bedside: A Call for In Vivo Preclinical Models to Advance Endometrial Cancer and Cervical Cancer Immuno-oncology Research

Suchergebnisse filtern